Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain

[图书][B] Botulinum toxin treatment of pain disorders

B Jabbari - 2015 - Springer
Since the first edition of this book in 2015, much has developed regarding the basic and the
clinical science of botulinum neurotoxin (BoNT) therapy in pain disorders. Basic scientists …
保存 引用 被引用次数：35 相关文章 所有 5 个版本 图书馆搜索
[Free GPT-4]
[PDF] sciencedirect.com

Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors

F Azzaz, D Hilaire, J Fantini - Chemico-biological Interactions, 2023 - Elsevier
Abstract Botulinum neurotoxin A1 (BoNT/A1) is the most potent natural poison in human.
BoNT/A1 recognize the luminal domain of SV2A (LD-SV2A) and its glycosylation at position …
保存 引用 被引用次数：6 相关文章 所有 7 个版本
[Free GPT-4]
[PDF] archive.org

[PDF][PDF] All-atom Molecular Dynamics Simulation of botulinum neurotoxin serotype A1 in complex with human SV2A or SV2C receptors in a lipid raft environment

F Azzaz, D Hilaire, J Fantini - scholar.archive.org
Abstract Botulinum neurotoxin A1 (BoNT/A1) is the most potent serotype in humans with the
highest clinical duration. BoNT/A1 interacts with synaptic vesicle glycoprotein 2 (SV2) and …
保存 引用 相关文章 HTML 版

Future Prospects of Pain Treatment with Botulinum Neurotoxins

B Jabbari - Botulinum Toxin Treatment of Pain Disorders, 2022 - Springer
The treatment of pain with botulinum neurotoxins is now entering a new era due to the
discovery of new peripheral and central pain receptors and the emergence of newly …
保存 引用 相关文章 所有 2 个版本